Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bristol-Myers says Phase 3 study of nivolumab versus dacarbazine stopped early
Yahoo/Fly on the Wall
Tuesday, June 24, 2014 - 5:15pm
tags:
nivolumab, Bristol-Myers Squibb, dacarbazine, melanoma
Hologic's 3-D Mammogram Makes Better Breast Cancer Test, Study Says
Bloomberg
Tuesday, June 24, 2014 - 4:49pm
tags:
Hologic, 3-D mammograms, breast cancer
California biotech IPOs burgeoning, thanks in part to federal law
LA Times, CA
Tuesday, June 24, 2014 - 4:46pm
tags:
California, biotech, IPOs
Abbott Laboratories: Recent Emerging Market Acquisitions Boost Growth Profile
Seeking Alpha
Tuesday, June 24, 2014 - 4:35pm
tags:
Abbott Laboratories, emerging markets, M&A, AbbVie, Veropharm
AstraZeneca Gets a Chance to Prove Its Worth to Pfizer
Motley Fool
Tuesday, June 24, 2014 - 4:33pm
tags:
AstraZeneca, Pfizer, olaparib, ovarian cancer
FDA warns GSK on manufacturing practices at Canada plant
Reuters
Tuesday, June 24, 2014 - 10:28am
tags:
FDA, GSK, Canada, drug manufacturing
Lundbeck Completes Acquisition of Chelsea Therapeutics; NORTHERA™ (droxidopa) is expected to be available to patients in the U.S. during the fall of this year
Yahoo
Tuesday, June 24, 2014 - 10:26am
tags:
Lundbeck, Chelsea Therapeutics, Northera, neurogenic orthostatic hypotension
R&D budgets soar as cash-laden biotechs spend big on research
Fierce Biotech
Tuesday, June 24, 2014 - 10:24am
tags:
biotech, R&D
Isis Pharmaceuticals receives $1M milestone payment from GlaxoSmithKline
The Fly on the Wall
Tuesday, June 24, 2014 - 10:22am
tags:
GSK, Isis Pharmaceuticals, ISIS-TTRRx, familial amyloid polyneuropathy
Generic Drug Probes, SEC Committee, HSBC Hire: Compliance
Bloomberg
Tuesday, June 24, 2014 - 10:20am
tags:
generics, SEC, compliance, competition, Forest Labs, Endo Health Solutions
Does the Medtronic-Covidien mega-merger leave startups in the cold?
Mass Device
Tuesday, June 24, 2014 - 10:17am
tags:
Medtronic, Covidien, devices, M&A
What Impact Will Hepatitis C Drugs Have on Medical Costs? Look Here
WSJ Online
Tuesday, June 24, 2014 - 9:59am
tags:
hepatitis C, Gilead Sciences, Sovaldi
Cubist and Durata Heat Up Antibiotic Market
Motley Fool
Tuesday, June 24, 2014 - 9:51am
tags:
Cubist Pharmaceuticals, Durata Therapeutics, antibiotics, Dalvance, Sivextro, ceftolozane/tazobactam
Endo to acquire DAVA Pharmaceuticals for $575M
Yahoo/Fly on the Wall
Tuesday, June 24, 2014 - 9:37am
tags:
Endo Health Solutions, Dava Pharmaceuticals, M&A
In A Victory For Gene Research, Vertex Drug Combo Clears Lungs Clogged By Cystic Fibrosis
Forbes
Tuesday, June 24, 2014 - 9:15am
tags:
Vertex Pharmaceuticals, cystic fibrosis, Kalydeco, lumacaftor
[video]How Bad Is This Delay for Orexigen Therapeutics, Inc?
Motley Fool
Tuesday, June 24, 2014 - 9:12am
tags:
Contrave, FDA, obesity, Orexigen
Bank Analysts Say Pfizer-AstraZeneca Merger Still Makes Sense
NY Times, NY
Tuesday, June 24, 2014 - 9:11am
tags:
Pfizer, AstraZeneca, M&A
Bristol-Myers Squibb's Oncology Opportunity
Motley Fool
Tuesday, June 24, 2014 - 9:11am
tags:
Bristol-Myers Squibb, Yervoy, melanoma
Will GlaxoSmithKline plc Become A Bid Target?
Motley Fool
Tuesday, June 24, 2014 - 9:09am
tags:
GSK, JNJ, Novartis, M&A
Merrimack Falls Steeply as Sanofi Returns Oncology Drug Rights
Yahoo/Zacks.com
Monday, June 23, 2014 - 7:52pm
tags:
Sanofi, Merrimack Pharmaceuticals, MM-121

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.